{"doi":"10.1128/mbio.02701-22","title":"Transcriptional Biomarkers of Differentially Detectable Mycobacterium tuberculosis in Patient Sputum","abstract":"<jats:p>\n            Differentially detectable\n            <jats:named-content content-type=\"genus-species\">M. tuberculosis</jats:named-content>\n            (DD\n            <jats:named-content content-type=\"genus-species\">M. tuberculosis</jats:named-content>\n            ), which is detectable by limiting dilution assays but not by CFU, is present and enriched for in TB patient sputum after initiation of first-line therapy. These cryptic cells may play a role in disease persistence due to their phenotypic tolerance to anti-TB drugs.\n          </jats:p>","journal":"mBio","year":2022,"id":13704,"datarank":0.5023879475731653,"base_score":2.302585092994046,"endowment":2.302585092994046,"self_citation_contribution":0.3453877639491069,"citation_network_contribution":0.15700018362405838,"self_endowment_contribution":0.3453877639491069,"citer_contribution":0.15700018362405838,"corpus_percentile":null,"corpus_rank":null,"citation_count":9,"citer_count":8,"citers_with_citation_signal":6,"citers_with_endowment":6,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":111350,"name":"Kohta Saito","orcid":null,"position":1,"is_corresponding":false},{"id":111351,"name":"Saurabh Mishra","orcid":null,"position":2,"is_corresponding":false},{"id":111352,"name":"Kathleen Frances Walsh","orcid":"0000-0002-9001-3918","position":3,"is_corresponding":false},{"id":111353,"name":"Laurent Daniel Mathurin","orcid":null,"position":4,"is_corresponding":false},{"id":111354,"name":"Stalz Charles Vilbrun","orcid":null,"position":5,"is_corresponding":false},{"id":111355,"name":"Oksana Ocheretina","orcid":null,"position":6,"is_corresponding":false},{"id":111356,"name":"Jean William Pape","orcid":null,"position":7,"is_corresponding":false},{"id":111357,"name":"Daniel W. Fitzgerald","orcid":null,"position":8,"is_corresponding":false},{"id":111358,"name":"Carl F. Nathan","orcid":"0000-0002-7744-8896","position":9,"is_corresponding":false},{"id":111359,"name":"Myung Hee Lee","orcid":null,"position":10,"is_corresponding":false},{"id":111349,"name":"Kayvan Zainabadi","orcid":"0000-0003-3134-1783","position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":2.302585092994046,"endowment":2.302585092994046,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"36326252","pmcid":"PMC9765512","openalex_id":"https://openalex.org/W4308058527","authors":[],"funders":[{"funder_name":"HHS | NIH | Fogarty International Center","grant_id":"D43 TW009337","title":null},{"funder_name":"HHS | NIH | National Institute of Allergy and Infectious Diseases","grant_id":"U19 AI111143","title":null},{"funder_name":"HHS | NIH | National Institute of Allergy and Infectious Diseases","grant_id":"K08 AI139360","title":null},{"funder_name":"HHS | NIH | National Institute of Allergy and Infectious Diseases","grant_id":"K24AI098627","title":null},{"funder_name":"NIAID NIH HHS","grant_id":"U19 AI162568","title":null},{"funder_name":"NCATS NIH HHS","grant_id":"UL1 TR002384","title":null},{"funder_name":"National Institutes of Health","grant_id":"5K08AI139360-04","title":"Identifying the Molecular Target of Two Novel Compounds Active Against Non-replicating Mycobacterium tuberculosis and Delineating the Role of the Putative Target, InhA, in Non-replicating States"},{"funder_name":"National Institutes of Health","grant_id":"3D43TW009337-08S1","title":"Vanderbilt-Emory-Cornell-Duke Consortium for Global Health Fellows (VECDor)"},{"funder_name":"National Institutes of Health","grant_id":"5U19AI111143-04","title":"Tri-Institutional TB Research Unit: Persistence and Latency"},{"funder_name":"National Institutes of Health","grant_id":"5K24AI098627-09","title":"Global Health Research Training in HIV and Tuberculosis"}],"total_grants":10,"fwci":0.8064,"citation_percentile":0.73204053,"influential_citations":0,"citation_trend":[{"year":2021,"count":1},{"year":2023,"count":4},{"year":2024,"count":1},{"year":2025,"count":3}],"oa_status":"gold","license":"cc-by","oa_locations":[{"url":"https://doi.org/10.1128/mbio.02701-22","host_type":"journal"},{"url":"https://doi.org/10.1128/mbio.02701-22","host_type":"GOLD"},{"url":"https://doi.org/10.1128/mbio.02701-22","host_type":"publisher"},{"url":"https://journals.asm.org/doi/pdf/10.1128/mbio.02701-22","host_type":"publisher"},{"url":"https://pubmed.ncbi.nlm.nih.gov/36326252","host_type":"repository"},{"url":"https://doaj.org/article/7f1255c430cb4df1aa418cf9a72e72d4","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9765512","host_type":"repository"},{"url":"https://europepmc.org/articles/PMC9765512","host_type":"Europe_PMC"},{"url":"https://europepmc.org/articles/PMC9765512?pdf=render","host_type":"Europe_PMC"},{"url":"http://dx.doi.org/10.1128/mbio.02701-22","host_type":""}],"fields_of_study":["Tuberculosis Research and Epidemiology","Mycobacterium research and diagnosis","Biochemical and Molecular Research","Medicine","Biology","0301 basic medicine","03 medical and health sciences","Humans","Mycobacterium tuberculosis","Sputum","RNA, Ribosomal, 16S","Antitubercular Agents","Tuberculosis","Rifampin","Sensitivity and Specificity"],"mesh_terms":["Antitubercular Agents","Humans","Mycobacterium tuberculosis","Rifampin","RNA, Ribosomal, 16S","Sensitivity and Specificity","Sputum","Tuberculosis"],"keywords":["Tuberculosis","Mycobacterium tuberculosis","Sputum","Microbiology","Medicine","Tuberculosis diagnosis","Biology","Pathology","Multidrug resistance","Persistence","Diagnostics","Molecular Methods","Clinical Methods","Viable But Nonculturable","Differentially Detectable Bacteria","Antitubercular Agents","Sensitivity and Specificity","QR1-502","RNA, Ribosomal, 16S","Humans","Rifampin","Research Article"],"sdg_mappings":[{"sdg_number":3,"sdg_label":"3. Good health"},{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-05-31T10:31:02.870632Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}